Cytotherapy

Cytotherapy, also known as cellular therapy or cell-based therapy, is a rapidly evolving field in regenerative medicine that involves the use of living cells as therapeutic agents to treat diseases, injuries, and disorders. Unlike traditional pharmaceutical drugs, which typically act on biochemical pathways or targets, cytotherapy harnesses the regenerative and immunomodulatory properties of cells to promote tissue repair, regeneration, and immune modulation. One of the most widely studied forms of cytotherapy is stem cell therapy, which utilizes stem cells, such as mesenchymal stem cells (MSCs), embryonic stem cells (ESCs), or induced pluripotent stem cells (iPSCs), for therapeutic purposes. Stem cell therapies have shown promise in treating a wide range of conditions, including cardiovascular diseases, neurodegenerative disorders, orthopaedic injuries, and autoimmune diseases. Another form of cytotherapy involves the use of immune cells, such as T cells, natural killer (NK) cells, or dendritic cells, to modulate the immune response and target cancer cells or pathogens. Adoptive cell therapy, which involves the isolation, expansion, and infusion of patient-derived or donor-derived immune cells, has emerged as a powerful approach for treating cancer and infectious diseases. Chimeric antigen receptor (CAR) T-cell therapy, in which T cells are genetically engineered to express receptors targeting specific antigens on cancer cells, has shown remarkable success in treating certain types of leukemia and lymphoma.